Genmont Biotech reports Aug revenue of NT$30.3M vs NT$26.2M
Genmont Biotech Inc. reported 2026 revenue of NT$30,302,000 versus NT$26,236,000 in 2025. Jan-Aug revenue was NT$250,356,000 versus NT$269,499,000, per the Taiwan Stock Exchange.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Genmont Biotech Inc. reported 2026 revenue of NT$30,302,000 versus NT$26,236,000 in 2025. Jan-Aug revenue was NT$250,356,000 versus NT$269,499,000, per the Taiwan Stock Exchange.